{"id":45948,"date":"2025-11-06T00:11:49","date_gmt":"2025-11-05T16:11:49","guid":{"rendered":"https:\/\/flcube.com\/?p=45948"},"modified":"2025-11-06T00:11:50","modified_gmt":"2025-11-05T16:11:50","slug":"baheal-pharma-locks-csl-behring-albumin-rights-to-boost-chinas-blood-product-supply","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45948","title":{"rendered":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply"},"content":{"rendered":"\n<p>Baheal Pharma Group (<a href=\"https:\/\/www.google.com\/finance\/quote\/301015:SHE\">SHE: 301015<\/a>), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with <strong>CSL Behring<\/strong> (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s <strong>Anbomei<\/strong> human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-highlights\">Key Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Detail<\/th><th>Information<\/th><\/tr><\/thead><tbody><tr><td><strong>Partnership Scope<\/strong><\/td><td>Exclusive promotion, sales, and distribution of Anbomei in specific Chinese markets<\/td><\/tr><tr><td><strong>Strategic Fit<\/strong><\/td><td>Combines CSL\u2019s globally\u2011leading blood product expertise with Baheal\u2019s robust commercialization network<\/td><\/tr><tr><td><strong>Market Impact<\/strong><\/td><td>Aims at meeting the rising demand for high\u2011quality blood products and improving patient outcomes<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-csl-behring-s-anbomei\">About CSL Behring\u2019s Anbomei<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Designed for China<\/strong> \u2013 Human albumin product engineered to meet local regulatory and clinical needs.<\/li>\n\n\n\n<li><strong>Room\u2011Temperature Stability<\/strong> \u2013 Can be stored up to 30\u202f\u00b0C, protected from light, eliminating the need for cold\u2011chain logistics.<\/li>\n\n\n\n<li><strong>Supply\u2011Chain Advantage<\/strong> \u2013 Reduces complexity and cost, ensuring rapid availability and resilience for healthcare providers.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-historical-context\">Historical Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>40\u2011Year Presence<\/strong> \u2013 CSL Behring has been a major human albumin supplier in China for nearly four decades.<\/li>\n\n\n\n<li><strong>Prior Retail Cooperation<\/strong> \u2013 The 2018 retail collaboration laid the groundwork for the current, expanded agreement.<\/li>\n\n\n\n<li><strong>Future Outlook<\/strong> \u2013 The enhanced partnership is expected to streamline access to albumin, a critical component in critical care and surgical settings.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-business-implications\">Business Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue Growth<\/strong> \u2013 Baheal\u2019s commercial platform will harness CSL\u2019s product portfolio, potentially increasing market share.<\/li>\n\n\n\n<li><strong>Operational Synergy<\/strong> \u2013 The partnership leverages CSL\u2019s manufacturing quality and Baheal\u2019s distribution strength.<\/li>\n\n\n\n<li><strong>Patient Benefit<\/strong> \u2013 Enhanced availability of albumin supports better outcomes for patients requiring transfusions and critical care.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-bottom-line\">Bottom Line<\/h2>\n\n\n\n<p>Baheal Pharma Group\u2019s new exclusive arrangement with CSL Behring marks a significant step in fortifying China\u2019s blood product ecosystem. By marrying CSL\u2019s industry\u2011leading albumin technology with Baheal\u2019s distribution capabilities, the deal promises to shorten supply chains, cut costs, and expand patient access to high\u2011quality albumin across mainland China.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45952,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[288,4433,2011],"class_list":["post-45948","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-baheal-pharmaceutical","tag-csl-behring","tag-she-301015"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with CSL Behring (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s Anbomei human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45948\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply\" \/>\n<meta property=\"og:description\" content=\"Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with CSL Behring (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s Anbomei human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45948\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-05T16:11:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-05T16:11:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply\",\"datePublished\":\"2025-11-05T16:11:49+00:00\",\"dateModified\":\"2025-11-05T16:11:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0512.webp\",\"keywords\":[\"Baheal Pharmaceutical\",\"CSL Behring\",\"SHE: 301015\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45948#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45948\",\"name\":\"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0512.webp\",\"datePublished\":\"2025-11-05T16:11:49+00:00\",\"dateModified\":\"2025-11-05T16:11:50+00:00\",\"description\":\"Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with CSL Behring (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s Anbomei human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45948\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0512.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0512.webp\",\"width\":1080,\"height\":608,\"caption\":\"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45948#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply - Insight, China&#039;s Pharmaceutical Industry","description":"Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with CSL Behring (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s Anbomei human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45948","og_locale":"en_US","og_type":"article","og_title":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply","og_description":"Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with CSL Behring (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s Anbomei human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.","og_url":"https:\/\/flcube.com\/?p=45948","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-05T16:11:49+00:00","article_modified_time":"2025-11-05T16:11:50+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45948#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45948"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply","datePublished":"2025-11-05T16:11:49+00:00","dateModified":"2025-11-05T16:11:50+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45948"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45948#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp","keywords":["Baheal Pharmaceutical","CSL Behring","SHE: 301015"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45948#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45948","url":"https:\/\/flcube.com\/?p=45948","name":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45948#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45948#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp","datePublished":"2025-11-05T16:11:49+00:00","dateModified":"2025-11-05T16:11:50+00:00","description":"Baheal Pharma Group (SHE: 301015), a prominent Chinese therapeutic manufacturer, announced an enhanced cooperation agreement with CSL Behring (CSL) that will grant Baheal exclusive rights to market, sell and distribute CSL\u2019s Anbomei human albumin product in selected mainland China territories, building on a successful partnership that began in 2018.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45948#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45948"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45948#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp","width":1080,"height":608,"caption":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45948#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Baheal Pharma Locks CSL Behring Albumin Rights to Boost China\u2019s Blood Product Supply"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0512.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45948"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45948\/revisions"}],"predecessor-version":[{"id":45953,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45948\/revisions\/45953"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45952"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}